Molecular Diagnostics Industry Executive, Dr. Heiner Dreismann, Joins ChondroGene Inc.'s Board

TORONTO, Sept. 19 /PRNewswire-FirstCall/ - ChondroGene Limited (TSX Venture: CDG - News) announced today that former Roche Molecular Systems CEO, Dr. Heiner Dreismann, PhD, has joined ChondroGene's Board of Directors. Dr. Dreismann is a veteran of the molecular diagnostics industry who will bring a wealth of experience, contacts and insight to ChondroGene as it moves into the commercialization of its blood-based molecular diagnostic tests.